{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:38:53Z","timestamp":1790127533480,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3446,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1038\/sj.ki.5001513","type":"journal-article","created":{"date-parts":[[2006,5,19]],"date-time":"2006-05-19T08:00:09Z","timestamp":1148025609000},"page":"170-176","source":"Crossref","is-referenced-by-count":36,"title":["Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats"],"prefix":"10.1016","volume":"70","author":[{"given":"O.","family":"Pechanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Matuskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Capikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Jendekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Paulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Simko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5001513_bb0010","first-page":"1","article-title":"Heart failure and angiotensin converting enzyme inhibition: problems and perspectives","volume":"48","author":"Simko","year":"1999","journal-title":"Physiol Res"},{"key":"10.1038\/sj.ki.5001513_bb0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1006\/jmcc.2000.1129","article-title":"Induction of cardiac fibrosis by aldosterone","volume":"32","author":"Lijnen","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/sj.ki.5001513_bb0020","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","article-title":"Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension","volume":"42","author":"White","year":"2003","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5001513_bb0025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5001513_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/147323000102900103","article-title":"Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy","volume":"29","author":"Sato","year":"2001","journal-title":"Int Med Res"},{"key":"10.1038\/sj.ki.5001513_bb0035","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00004872-200105000-00001","article-title":"Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift","volume":"19","author":"Epstein","year":"2001","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5001513_bb0040","doi-asserted-by":"crossref","first-page":"H2241","DOI":"10.1152\/ajpheart.2001.281.5.H2241","article-title":"Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure","volume":"281","author":"Francis","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/sj.ki.5001513_bb0045","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart. Role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.ki.5001513_bb0050","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.33549\/physiolres.930000.53.S23","article-title":"Altered balance of vasoactive systems in experimental hypertension: the role of relative NO deficiency","volume":"53","author":"Kunes","year":"2004","journal-title":"Physiol Res"},{"key":"10.1038\/sj.ki.5001513_bb0055","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1006\/jmcc.1997.0566","article-title":"Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril","volume":"29","author":"Pechanova","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/sj.ki.5001513_bb0060","first-page":"311","article-title":"Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats","volume":"45","author":"Bernatova","year":"1996","journal-title":"Physiol Res"},{"key":"10.1038\/sj.ki.5001513_bb0065","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/BF00169370","article-title":"Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency","volume":"350","author":"Hropot","year":"1994","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1038\/sj.ki.5001513_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/345161a0","article-title":"Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide","volume":"345","author":"Myers","year":"1990","journal-title":"Nature"},{"key":"10.1038\/sj.ki.5001513_bb0075","first-page":"739","article-title":"Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates","volume":"218","author":"Ignarro","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/sj.ki.5001513_bb0080","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.lfs.2003.07.032","article-title":"Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension","volume":"74","author":"Simko","year":"2004","journal-title":"Life Sci"},{"key":"10.1038\/sj.ki.5001513_bb0085","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1469-445X.1999.01890.x","article-title":"Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney","volume":"84","author":"Bernatova","year":"1999","journal-title":"Exp Physiol"},{"key":"10.1038\/sj.ki.5001513_bb0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/phrs.2001.0865","article-title":"Spironolactone and captopril attenuates isoproterenol-induced cardiac remodeling in rats","volume":"44","author":"Gallego","year":"2001","journal-title":"Pharmacol Res"},{"key":"10.1038\/sj.ki.5001513_bb0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/sj.ki.5001513_bb0100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0891-5849(97)00014-2","article-title":"Antioxidant and prooxidant properties of captopril and enalapril","volume":"23","author":"Bartosz","year":"1997","journal-title":"Free Rad Biol Med"},{"key":"10.1038\/sj.ki.5001513_bb0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/jmcc.1999.1071","article-title":"Regression of chronic L-NAME-treatment-induced left ventricular hypertrophy: effect of captopril","volume":"32","author":"Bernatova","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/sj.ki.5001513_bb0110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1749-6632.2002.tb04304.x","article-title":"Impaired endothelial function of thoracic aorta in hereditary hypertriglyceridemic rats","volume":"967","author":"Torok","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1038\/sj.ki.5001513_bb0115","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1055\/s-0037-1613404","article-title":"Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition","volume":"89","author":"Schafer","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1038\/sj.ki.5001513_bb0120","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.HYP.37.2.801","article-title":"Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension","volume":"37","author":"Quaschning","year":"2001","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5001513_bb0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0344-0338(00)80060-6","article-title":"Effect of antihypertensive drugs on the myocardial microvessels in rats with nitric oxide blockade","volume":"196","author":"Pereira","year":"2000","journal-title":"Pathol Res Pract"},{"key":"10.1038\/sj.ki.5001513_bb0130","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0895-7061(98)00051-X","article-title":"Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis","volume":"11","author":"Akuzawa","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1038\/sj.ki.5001513_bb0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.33549\/physiolres.930000.49.37","article-title":"The potential role of nitric oxide in the hypertrophic growth of the left ventricle","volume":"49","author":"Simko","year":"2000","journal-title":"Physiol Res"},{"key":"10.1038\/sj.ki.5001513_bb0140","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1073\/pnas.89.16.7674","article-title":"Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin","volume":"89","author":"Stamler","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.ki.5001513_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.33549\/physiolres.930000.49.55","article-title":"Effect of captopril on cyclic nucleotide concentrations during long-term NO synthase inhibition","volume":"49","author":"Pechanova","year":"2000","journal-title":"Physiol Res"},{"key":"10.1038\/sj.ki.5001513_bb0150","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/01.HYP.30.6.1621","article-title":"Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis","volume":"30","author":"Takemoto","year":"1997","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5001513_bb0155","first-page":"H52","article-title":"Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo","volume":"274","author":"Devlin","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1038\/sj.ki.5001513_bb0160","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/01.HYP.30.6.1621","article-title":"Chronic angiotensin-converting enzyme inhibition and angiotensin II type receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis","volume":"30","author":"Takemoto","year":"1997","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5001513_bb0165","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000075945","article-title":"Effects of eplerenone on heart and kidney in two-kidney, one-clip rats","volume":"24","author":"Hao","year":"2004","journal-title":"Am J Nephrol"},{"key":"10.1038\/sj.ki.5001513_bb0170","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5001513_bb0175","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1046\/j.1523-1755.2000.00055.x","article-title":"Effects of spironolactone on systolic blood pressure in experimental diabetic rats","volume":"57","author":"Liu","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001513_bb0180","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1097\/01.ASN.0000027354.12330.F4","article-title":"Evidence for the existence of two distinct functions for the inducible NO synthase in the rat kidney: effect of aminoguanidine in rats with 5\/6 ablation","volume":"13","author":"Fujihara","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001513_bb0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ki.1997.317","article-title":"Renal and systemic nitric oxide synthesis in rats with renal mass reduction","volume":"52","author":"Aiello","year":"1997","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001513_bb0190","first-page":"15","article-title":"Glomerular profile numerical density per area and mean glomerular volume in rats submitted to nitric oxide synthase blockade","volume":"16","author":"Pereira","year":"2001","journal-title":"Histol Histopathol"},{"key":"10.1038\/sj.ki.5001513_bb0195","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00210-002-0682-3","article-title":"Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insuficiency induced by chronic NO-synthase inhibition in rats","volume":"367","author":"Hropot","year":"2003","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1038\/sj.ki.5001513_bb0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000088829","article-title":"Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat","volume":"28","author":"Khattab","year":"2005","journal-title":"Kidney Blood Press Res"},{"key":"10.1038\/sj.ki.5001513_bb0205","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1073\/pnas.87.2.682","article-title":"Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme","volume":"87","author":"Bredt","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.ki.5001513_bb0210","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"key":"10.1038\/sj.ki.5001513_bb0215","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1039\/an9588300670","article-title":"A scheme for colorimetric determination of microgram amounts of thiols","volume":"83","author":"Saville","year":"1958","journal-title":"Analyst"},{"key":"10.1038\/sj.ki.5001513_bb0220","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0003-2697(69)90064-5","article-title":"Enzymic method for quantitative determination of nanogram amounts of total oxidized glutathione: applications to mammalian blood and other tissues","volume":"27","author":"Tietze","year":"1969","journal-title":"Anal Biochem"},{"key":"10.1038\/sj.ki.5001513_bb0225","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/abbi.1997.9956","article-title":"Effect of thiol status on nitric oxide metabolism in the circulation","volume":"341","author":"Minamiyama","year":"1997","journal-title":"Arch Biochem Biophys"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815517547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815517547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:50:24Z","timestamp":1736383824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815517547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0085253815517547"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5001513","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}